Epilepsy Research
Volume 22, Issue 1 , Pages 13-21 , September 1995

Reduced function of γ-aminobutyric acidA receptors in tottering mouse brain: Role of cAMP-dependent protein kinase

Received 28 November 1994 ,Accepted 19 April 1995.

References 

  1. Allan AM, Harris A. γ-Aminobutyric acid agonists and antagonists alter chloride flux across brain membranes. Mol. Pharmacol. 1986;29:497–505
  2. Angelotti TP, Uhler MD, Macdonald RL. Enhancement of recombinant γ-aminobutyric acid type A receptor currents by chronic activation of cAMP-dependent protein kinase. Mol. Pharmacol. 1993;44:1202–1210
  3. Barnes EM, Tehrani MHJ. Alteration of central benzodiazepine receptor subtypes in the cerebral cortex of the mutant tottering. Soc. Neurosci. Abs. 1990;16:782
  4. Barnes EM, Tehrani MHJ. Reduced GABAA receptor function and elevated cAMP-dependent protein kinase activity in tottering mouse brain. Soc. Neurosci. Abs. 1994;20:503
  5. Booker JG, Dailey JW, Jobe PC, Lane JD. Cerebral cortical GABA and benzodiazepine binding sites in genetically seizure prone rats. Life Sci. 1986;39:799–806
  6. Browning MD, Endo S, Smith GB, Dudek EM, Olsen RW. Phosphorylation of the GABAA receptor by cAMP-dependent protein kinase and protein kinase C: Analysis of the substrate domain. Neurochem. Res. 1993;18:95–100
  7. Chermat R, Doare L, Lachapelle F, Simon P. Effects of drugs affecting the noradrenergic system on convulsions in the quaking mouse. Naunyn Schmiedebergs Arch. Pharmacol. 1981;318:94–99
  8. Cheun JE, Yeh HH. Modulation of GABAA receptor-activated current by norepinephrine in cerebellar Purkinje cells. Neuroscience. 1992;51:951–960
  9. Crill WE. Neurophysiological basis of convulsive disorders. In:  Tunnicliff G,  Raess BU editor. GABA Mechanisms in Epilepsy. New York: Wiley-Liss; 1991;p. 31–46
  10. Crunelli V, Leresche N. A role for GABAB receptors in excitation and inhibition of thalamocortical cells. Trends Neurol. Sci. 1991;14:16–21
  11. Enna SJ, Beutler JA. GABA receptor as a site for antiepileptic drug action. In:  Bartholini G,  Bossi L,  Lloyd KG,  Morselli PL editor. Epilepsy and GAGA Recep tor Agonists: Basic and Therapeutic Research. New York: Raven Press; 1985;p. 195–210
  12. Giembycz MA, Diamond J. Evaluation of kemptide, a synthetic serine-containing heptapetide, as a phosphate acceptor for the estimation of cAMP-dependent protein kinase activity in respiratory tissues. Biochem. Pharmacol. 1990;39:271–283
  13. Gloor P, Fariello RG. Generalized epilepsy: Some of its cellular mechanisms differ for those of focal epilepsy. Trends Neurol. Sci. 1988;11:63–68
  14. Hattori H, Ito M, Mikawa H. γ-Aminobutyric acid, benzodiazepine binding sites and γ-aminobutyric acid concentrations in epileptic El mouse brain. Eur. J. Pharmacol. 1985;119:217–223
  15. Helekar SA, Noebels JL. Synchronous hippocampal bursting reveals excitability defects in an epilepsy gene mutation. In: 2nd ed.. Proc. Natl. Acad. Sci. USA. 88:1991;p. 4736–4740
  16. Helekar SA, Noebels JL. Analysis of voltage gated and synaptic conductance contributing to network excitability defects in the mutant mouse tottering. J. Neurophysiol. 1994;71:1–10
  17. Heuschneider G, Schwartz RD. cAMP and forskolin decrease γ-aminobutyric acid-gated chloride flux in rat brain synaptoneurosomes. In: 2nd ed.. Proc. Natl. Acad. Sci. USA. 86:1989;p. 2938–2942
  18. Horton RW, Collins JF, Anlezark G, Meldrum BS. γ-Aminobutyric acid and benzodiazepine binding sites in audiogenic seizure-susceptible mice. J. Neurochem. 1982;39:864–870
  19. Knight AR, Bowery NG. GABA receptors in rats with spontaneous generalized nonconvulsive epilepsy. J. Neural Transm. [Suppl.]. 1992;35:189–196
  20. Leidenheimer NJ, Machu TK, Endo S, Olsen RW, Harris RA, Browning MD. Cyclic-AMP dependent protein kinase decreases γ-aminobutyric acidA receptor mediated 36Cl− uptake by brain microsacs. J. Neurochem. 1991;57:722–725
  21. Levitt P, Noebels JL. Mutant mouse tottering: Selective increase of locus coemleus axons in a defined single locus mutation. In: 2nd ed.. Proc. Natl. Acad. Sci. USA. 78:1981;p. 4630–4634
  22. Levitt P, Lau C, Pylypiw A, Ross LL. Central adrenergic receptor changes in inherited noradrenergic hyperinnervated mutant mouse tottering. Brain Res. 1987;418:174–177
  23. Liles WC, Taylor S, Finnel R, Lai H, Nathanson NM. Decreased muscarinic acetylcholine receptor number in the central nervous system of the tottering (tg/tg) mouse. J. Neurochem. 1986;46:977–982
  24. Ludvig N, Moshe SL. Different behavioral and electrographic effects of acoustic stimulation and dibutyryl cyclic AMP injection into the inferior colliculus in normal and in genetically epilepsy-prone rats. Epilepsy Res. 1989;3:185–190
  25. Madison DV, Nicoll RA. Norepinephrine decreases synaptic inhibition in the rat hippocampus. Brain Res. 1988;442:131–138
  26. Meldrum B, Braestrup C. GABA and the anticonvulsant action of benzodiazepines and related drugs. In:  Bowery NG editors. Actions and Interactions of GABA and Benzodiazepines. New York: Raven Press; 1985;p. 133–153
  27. Moss SJ, Smart TG, Blackstone CD, Huganir RL. Functional modulation of GABAA receptors by CAMP-dependent phosphorylation. Science. 1992;257:661–665
  28. Murray KJ, Leigh BK. Effects of detergents on the assay and activity of the cyclic AMP-dependent protein kinase. Biochem. Soc. Trans. 1986;14:1118–1119
  29. Murray KJ, England PJ, Lynham JA, Mills D, Schmitz-Peiffer C, Reeves ML. Use of a synthetic decapeptide (malantide) to measure the cyclic AMP-dependent protein kinase activity ratio in a variety of tissues. Biochem. J. 1990;267:703–708
  30. Noebels JL. A single gene error of noradrenergic axon growth synchronizes central neurons. Nature. 1984;310:409–411
  31. Noebels JL, Rutecki PA. Altered hippocampal network excitability in the hypernoradrenergic mutant mouse tottering. Brain Res. 1990;524:225–230
  32. Noebels JL, Sidman RL. Inherited epilepsy: spikewave seizures and focal motor seizures in the mutant mouse tottering. Science. 1979;204:1334–1336
  33. Olsen RW, Wamsley JK, McCabe RT, Lee RJ, Lomax P. Benzodiazepine/γ-aminobutyric acid receptor deficit in the midbrain of the seizure-susceptible gerbil. In: 2nd ed.. Proc. Nod. Acad. Sci. USA. 82:1985;p. 6701–6707
  34. Porter NM, Twyman RE, Uhler MD, Macdonald RL. Cyclic AMP-dependent protein kinase decreases GABAA receptor current in mouse spinal cord neurons. Neuron. 1990;4:789–796
  35. Psarropulou C, Angelatou F, Matsokis N, Kostopoulos G. Absence of modification in GABA and benzodiazepine binding and choline acetyltransferase activity in brain areas of the epileptic mutant mouse tottering. Gen. Pharmacol. 1987;18:593–597
  36. Schwartz RD, Heuschneider G, Edgar PP, Cohn JA. cAMP analogs inhibit γ-aminobutyric acid-gated chloride flux and activate protein kinase A in brain synaptoneurosomes. Mol. Pharmacol. 1991;39:370–375
  37. Spreafico R, Mennini T, Danober L, Cagnotto A, Regondi MC, Miari A, et al. GABAA receptor impairment in the genetic absence epilepsy rats from Strasbourg (GAERS): An immunocytochemical and receptor binding autoradiography study. Epilepsy Res. 1993;15:229–238
  38. Tehrani MHJ, Hablitz JJ, Barnes EM. cAMP increases the rate of GABAA receptor desensitization in chick cortical neurons. Synapse. 1989;4:126–131
  39. Tehrani MHJ, Barnes EM. Basal and drug-induced CAMP levels in cortical slices from the tottering mouse. Epilepsy Res. 1990;7:205–209
  40. Tehrani MHJ, Barnes EM. GABAA receptors in mouse cortical homogenates are phosphorylated by endogenous protein kinase A. Mol. Brain Res. 1994;24:55–64
  41. Wolf-Dieter R, Heuschneider G, Sperk G, Riederer P. Biochemical events in spontaneous seizures in the Mongolian gerbil. Metab. Brain Res. 1989;4:3–7

PII: 0920-1211(95)00033-7

Epilepsy Research
Volume 22, Issue 1 , Pages 13-21 , September 1995

Article Tools